Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Taiwan Clear all

270 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20035
20045
20058
200610
20078
200813
200913
201028
201121
201211
201312
201412
20159
20165
201714
201810
201911
20209
20218
202212
202311
202410
20257
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed184
Unknown status30
Terminated21
Recruiting18
Not yet recruiting9
Active, not recruiting5
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S33
AstraZeneca31
Eli Lilly and Company23
Boehringer Ingelheim20
National Taiwan University Hospital16
Sanofi11
Chang Gung Memorial Hospital10
Taipei Veterans General Hospital, Taiwan8
Takeda7
Bayer6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2270
Diabetes Mellitus53
Obesity12
Renal Insufficiency, Chronic11
Hyperglycemia9
Cardiovascular Diseases8
Hypertension8
Insulin Resistance8
Overweight8
Diabetic Nephropathies7

Trials

Showing 51 to 75 of 270. Each trial links to its page on Pharma Observatory.

170 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.